- Home
- CLDX vs IRS Comparison
CLDX vs IRS Comparison
Compare CLDX & IRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDX
- IRS
- Stock Information
- Founded
- CLDX N/A
- IRS 1943
- Country
- CLDX United States
- IRS Argentina
- Employees
- CLDX N/A
- IRS N/A
- Industry
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- IRS Homebuilding
- Sector
- CLDX Health Care
- IRS Real Estate
- Exchange
- CLDX Nasdaq
- IRS Nasdaq
- Market Cap
- CLDX 1.3B
- IRS 1.1B
- IPO Year
- CLDX 2008
- IRS 1994
- Fundamental
- Price
- CLDX $23.36
- IRS $14.37
- Analyst Decision
- CLDX Buy
- IRS Strong Buy
- Analyst Count
- CLDX 9
- IRS 1
- Target Price
- CLDX $50.00
- IRS $12.62
- AVG Volume (30 Days)
- CLDX 1.1M
- IRS 171.9K
- Earning Date
- CLDX 08-07-2025
- IRS 09-02-2025
- Dividend Yield
- CLDX N/A
- IRS 7.00%
- EPS Growth
- CLDX N/A
- IRS N/A
- EPS
- CLDX N/A
- IRS 0.20
- Revenue
- CLDX $7,559,000.00
- IRS $308,539,877.00
- Revenue This Year
- CLDX N/A
- IRS N/A
- Revenue Next Year
- CLDX N/A
- IRS N/A
- P/E Ratio
- CLDX N/A
- IRS $6.37
- Revenue Growth
- CLDX 24.49
- IRS N/A
- 52 Week Low
- CLDX $14.40
- IRS $7.93
- 52 Week High
- CLDX $47.00
- IRS $17.67
- Technical
- Relative Strength Index (RSI)
- CLDX 64.61
- IRS 49.90
- Support Level
- CLDX $20.76
- IRS $14.06
- Resistance Level
- CLDX $23.55
- IRS $14.74
- Average True Range (ATR)
- CLDX 1.22
- IRS 0.54
- MACD
- CLDX 0.20
- IRS 0.03
- Stochastic Oscillator
- CLDX 95.29
- IRS 53.91
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
About IRS IRSA Inversiones Y Representaciones S.A. Global Depositary Shares (Each representing ten shares of)
IRSA Inversiones y Representaciones SA is engaged in a diversified business. The company's operating segment includes Shopping Malls; Offices; Sales and Developments; Hotels and others. It generates maximum revenue from the Shopping Malls segment. The Shopping Malls segment comprised of lease and service revenues related to rental of commercial space and other spaces in the shopping malls of the company.